Cargando…

Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women

BACKGROUND: TIMP-2 gene plays an important role in the development of breast cancer. The present study was conducted to evaluate whether TIMP-2 gene polymorphisms are associated with breast cancer risk in a Han Chinese cohort. METHODS: Six single nucleotide polymorphisms (SNPs) within the TIMP-2 gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kai, Wang, Guanying, Huang, Shangke, Luo, Anqi, Jing, Xin, Li, Gang, Zhou, Yi, Zhao, Xinhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518501/
https://www.ncbi.nlm.nih.gov/pubmed/31088428
http://dx.doi.org/10.1186/s12885-019-5655-8
_version_ 1783418462969790464
author Wang, Kai
Wang, Guanying
Huang, Shangke
Luo, Anqi
Jing, Xin
Li, Gang
Zhou, Yi
Zhao, Xinhan
author_facet Wang, Kai
Wang, Guanying
Huang, Shangke
Luo, Anqi
Jing, Xin
Li, Gang
Zhou, Yi
Zhao, Xinhan
author_sort Wang, Kai
collection PubMed
description BACKGROUND: TIMP-2 gene plays an important role in the development of breast cancer. The present study was conducted to evaluate whether TIMP-2 gene polymorphisms are associated with breast cancer risk in a Han Chinese cohort. METHODS: Six single nucleotide polymorphisms (SNPs) within the TIMP-2 gene in 571 breast cancer and 578 healthy control subjects were genotyped through the Agena MassARRAY. Logistic regression analysis was used to assess the influence of TIMP-2 polymorphisms on breast cancer. Functional annotation of TIMP-2 variants and TIMP-2 expression were analyzed by bioinformatics. RESULTS: Bioinformatics analysis found that rs4789936 was likely to affect transcription factor binding, motifs, DNase footprint, and DNase peaks; and TIMP-2 was under-expressed in breast cancer, the risk allele of rs4789936 was associated with increased expression of TIMP-2 in peripheral blood samples. Importantly, individuals carrying TIMP-2 rs2277698 T allele have a 19% lower risk of breast cancer than individuals with allele C, providing protection (OR = 0.81, 95%CI = 0.67–0.99, p = 0.041). In the breast cancer patients with c-erb positive and PR positive, when the CC genotype was used as a reference, individuals carrying the TT genotype increased the risk of breast cancer. Haplotype analysis showed “TCC” was associated with a reduced risk of breast cancer (OR = 0.79, 95%CI = 0.63–0.97, p = 0.028). CONCLUSION: Our study indicated that TIMP-2 rs2277698 was associated with breast cancer susceptibility.
format Online
Article
Text
id pubmed-6518501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65185012019-05-21 Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women Wang, Kai Wang, Guanying Huang, Shangke Luo, Anqi Jing, Xin Li, Gang Zhou, Yi Zhao, Xinhan BMC Cancer Research Article BACKGROUND: TIMP-2 gene plays an important role in the development of breast cancer. The present study was conducted to evaluate whether TIMP-2 gene polymorphisms are associated with breast cancer risk in a Han Chinese cohort. METHODS: Six single nucleotide polymorphisms (SNPs) within the TIMP-2 gene in 571 breast cancer and 578 healthy control subjects were genotyped through the Agena MassARRAY. Logistic regression analysis was used to assess the influence of TIMP-2 polymorphisms on breast cancer. Functional annotation of TIMP-2 variants and TIMP-2 expression were analyzed by bioinformatics. RESULTS: Bioinformatics analysis found that rs4789936 was likely to affect transcription factor binding, motifs, DNase footprint, and DNase peaks; and TIMP-2 was under-expressed in breast cancer, the risk allele of rs4789936 was associated with increased expression of TIMP-2 in peripheral blood samples. Importantly, individuals carrying TIMP-2 rs2277698 T allele have a 19% lower risk of breast cancer than individuals with allele C, providing protection (OR = 0.81, 95%CI = 0.67–0.99, p = 0.041). In the breast cancer patients with c-erb positive and PR positive, when the CC genotype was used as a reference, individuals carrying the TT genotype increased the risk of breast cancer. Haplotype analysis showed “TCC” was associated with a reduced risk of breast cancer (OR = 0.79, 95%CI = 0.63–0.97, p = 0.028). CONCLUSION: Our study indicated that TIMP-2 rs2277698 was associated with breast cancer susceptibility. BioMed Central 2019-05-14 /pmc/articles/PMC6518501/ /pubmed/31088428 http://dx.doi.org/10.1186/s12885-019-5655-8 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Kai
Wang, Guanying
Huang, Shangke
Luo, Anqi
Jing, Xin
Li, Gang
Zhou, Yi
Zhao, Xinhan
Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title_full Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title_fullStr Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title_full_unstemmed Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title_short Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
title_sort association between timp-2 gene polymorphism and breast cancer in han chinese women
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518501/
https://www.ncbi.nlm.nih.gov/pubmed/31088428
http://dx.doi.org/10.1186/s12885-019-5655-8
work_keys_str_mv AT wangkai associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT wangguanying associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT huangshangke associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT luoanqi associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT jingxin associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT ligang associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT zhouyi associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen
AT zhaoxinhan associationbetweentimp2genepolymorphismandbreastcancerinhanchinesewomen